After three years of legal proceedings, in September 2024, Emergent agreed to pay $40 million to settle the lawsuit from ...

On Monday, Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $8.6 which represents a slight increase of $0.88 or 11.40% from the prior close of $7.72. The stock opened at $8 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.93% of ...

Trading of currency options swelled to a record after Donald Trump’s victory in the US presidential election, as traders rushed to bet on further dollar gains.

Narcan Sales: $95 million, reflecting strong volume in the US public interest channel ... Emergent BioSolutions Inc (NYSE:EBS) completed the stabilization phase of its multiyear turnaround plan ahead ...